Invitro Toxicity Monitoring News

Join our team in Munich, April 10th-13th for a hands-on look at our full product range Analytica 2018 is only a few weeks away. During the four days of the event, key players and decision-makers in the laboratory industry will meet at the world’s largest industry gathering. For another year, Ahlstrom-Munksjö will be present to showcase our solutions for laboratory and ...

Mar. 27, 2018

By Ahlstrom-Munksjö

Bioprocess Control has developed a new flow cell with higher resolution for applications that require analysing ultra low gas production and consumption with demand on high accuracy and precision. The new flow cell can be utilised in all smart instruments, i.e. AMPTS II and AMPTS II Light, µFlow and the new Gas Endeavour. ...

Oct. 8, 2017

By Bioprocess Control Sweden AB

In July 2017, the European Commission’s (EC) Joint Research Center (JRC) published a report entitled Evaluation of the availability and applicability of computational approaches in the safety assessment of nanomaterials:  Final report of the Nanocomput ...

Jul. 25, 2017

By Bergeson & Campbell, P.C.

ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB Kit U.S. performed using the ELITe InGenius instrument, a fully automated sample-to-result system. This real-time PCR-based test utilizes ELITechGroup Molecular Diagnostics proprietary MGB Technology to target a highly conserved coding region for the ...

Dec. 8, 2016

By ELITech Group

During the latest Symposium on Gut Health in Production of Food Animals, November 14-16 2016, in Saint Louis, Missouri, Lysiane Dunière, Research scientist at Lallemand Animal Nutrition Ruminant Center of Excellence (Clermont-Ferrand, France), presented a poster on yeast cell fraction potential in food safety1. Laurent Dussert explains: “Farm animals can represent a reservoir of ...

Nov. 30, 2016

By Lallemand Animal Nutrition

BloodCenter of Wisconsin (BCW, part of Versiti) and Eastman Chemical Company (NYSE:EMN) have announced the results of a recent clinical trial evaluating a new plasticizer for blood bags. While di-2-ethylhexyl phthalate (DEHP) has provided the medical industry with a stable ortho-phthalate plasticizer for many years, regulatory trends and consumer demands will inevitably drive the industry to ...

Nov. 13, 2016

By Eastman Chemical Company

ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the assay is intended to detect 150 variants belonging to ...

Nov. 7, 2016

By ELITech Group

Among the most clinically significant multidrug-resistantbacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usuallyremain susceptible to polymyxins, interest in this old class of antibiotics has been recentlyrenewed. However, the increasing use of colistin explains why Enterobacterial strains resistantto colistin are increasingly reported worldwide. Currently ...

Oct. 16, 2016

By ELITech Group

...

Aug. 9, 2016

By Bioprocess Control Sweden AB

...

Aug. 3, 2016

By Bioprocess Control Sweden AB

...

Jul. 20, 2016

By Bioprocess Control Sweden AB

A new ASTM standard provides an easy-to-perform test method for growing different strains of Clostridium difficile spores, which are used by microbiologists to evaluate antimicrobial drugs. Spore crops grown using the test method (soon to be published as E3011, Test Method for in vitro Production of Clostridium Difficile Spores) will be used in laboratories to test the efficacy of drugs that ...

Aug. 17, 2015

By ASTM International

Agilent Technologies Inc. (NYSE: A) today announced that the China Food and Drug Administration has approved the company's SureScan Dx microarray scanner as a medical device for in vitro diagnostic use. "Bringing microarray scanning technology to clinical-quality standards is an important milestone in moving the advancement of genome-wide chromosome analysis to the clinic," said Dr. Richard Choy, ...

Jan. 26, 2015

By Agilent Technologies, Inc.

Bergeson & Campbell, P.C., is pleased to announce that Managing Partner Lynn L. Bergeson and the late Michael F. Cole prepared a chapter in a new book, Biointeractions of Nanomaterials, which covers a wide range of issues associated with the safety of nanomaterials in biological systems. The book, published on July 29, 2014, by ...

Sep. 8, 2014

By Bergeson & Campbell, P.C.

The Genotrace project, combining targeted research and technology transfer, aims at delivering an innovative test to improve the safety of chemical products, drugs, human and animal food and the environment. The project consortium is led by INRA (French National Institute for Agricultural Research) and includes CNRS (French National Center for Scientific Research), the University Toulouse III ...

Sep. 8, 2014

By INRA - French National Institute of Agronomical Research

Agilent Technologies Inc. (NYSE: A) today introduced SureGuide, the first in a new series of kits to advance genome editing and synthetic biology. The complete SureGuide workflow includes a SureGuide Cas9 Nuclease Kit, SureGuide gRNA Synthesis Kit and SureGuide gRNA Control Kit, all designed to work together for any lab interested in ...

Sep. 3, 2014

By Agilent Technologies, Inc.

Bergeson & Campbell, P.C., (B&C®) is pleased to announce that Managing Partner Lynn L. Bergeson and the late Michael F. Cole prepared a chapter in a new book,Biointeractions of Nanomaterials, which covers a wide range of issues associated with the safety of nanomaterials in biological systems. The book, published on July 29, 2014, by CRC Press, addresses issues related to the toxicity ...

Aug. 25, 2014

By Bergeson & Campbell, P.C.

On September 28, 2011, the U.S. Environmental Protection Agency (EPA) issued its final guidance on the weight-of-evidence (WoE) (Final WoE Guidance) analysis that it will use to evaluate the results of data submitted in response to test orders issued for Tier 1 screening under the Endocrine Disruptor Screening Program (EDSP). This WoE analysis, in turn, will be used to determine what substances ...

Nov. 5, 2011

By Bergeson & Campbell, P.C.

On September 28, 2011, the U.S. Environmental Protection Agency (EPA) issued its final guidance on the weight-of-evidence (WoE) (Final WoE Guidance) analysis that it will use to evaluate the results of data submitted in response to test orders issued for Tier 1 screening under the Endocrine Disruptor Screening Program (EDSP). This WoE analysis, in turn, will be used to determine what substances ...

Oct. 4, 2011

By Acta Group

BSI Group America Inc., a leading provider of total solutions for certification and standards announces the launch of Specialized Regulatory Training courses targeted specifically for the medical device industry. Available on-site, these Specialized Regulatory Courses reflect requirements of the latest amendments to the Medical Device Directive enabling attendees to comply efficiently with ...

Apr. 26, 2011

By BSI